Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 491Lung Neoplasms 208Adenocarcinoma of Lung 49Small Cell Lung Carcinoma 34Neoplasms 31Adenocarcinoma, Bronchiolo-Alveolar 25Neoplasm Metastasis 20Breast Neoplasms 20Ovarian Neoplasms 19Colorectal Neoplasms 16Carcinoma 14Squamous Cell Carcinoma of Head and Neck 13Parkinson Disease 4, Autosomal Dominant Lewy Body 13Melanoma 13Carcinoma, Ovarian Epithelial 12Stomach Neoplasms 11Carcinoma, Renal Cell 9Head and Neck Neoplasms 8Respiratory Tract Neoplasms 7Prostatic Neoplasms 7Pancreatic Neoplasms 7Endometrial Neoplasms 7Thoracic Neoplasms 6Pleural Effusion, Malignant 6Lung Diseases 6Esophageal Neoplasms 6Colonic Neoplasms 6Carcinoma, Squamous Cell 6Adenocarcinoma 6Non-Squamous Non-Small Cell Lung Cancer 5

Interventions

cemiplimab 1Paclitaxel 1Gemcitabine 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Squamous Non-Small Cell Lung Cancer × Paclitaxel × Thoracic × Clear all
NCT07418931 2026-02-18

CECYDE

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting
108 enrolled
Thoracic

Advanced Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡